The Motley Fool Discussion Boards

Previous Page

Investing/Strategies / New Paradigm Investing


Subject:  Re: Let's Refine the P/S Discussion Date:  12/9/2018  8:31 AM
Author:  dumaflotchie Number:  106464 of 115955

You left out ABMD. (Current P/S=20.7. Before the recent downturn, was >30.)

Thanks Brer:

I didn’t have it in the original spreadsheet but joined the P/S >20 club in early 2018 when it tripled in price and had a P/S at its peak of 34.....previous years have been 4-13 going back to 2008.

From that peak of 34, the stock has declined 29% but from the point that it first hit 20 in feb 2018, the stock is up 18%.

But you also raise a question regarding biotech stocks that trade on little to no revenue.....I suppose these would therefore be excluded.....but ABMD is not quite biotech perhaps?
Copyright 1996-2020 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us